Particulate Analysis

Particulate analysis testing evaluates the presence, size, and quantity of particles released from medical devices during use. This is critical for devices that come into contact with the vascular system, such as catheters or stents, where particulates can pose serious health risks. The testing involves extracting particles from the device and analyzing them to assess potential toxicity, immunological response, or physical blockage. It helps ensure patient safety and regulatory compliance by identifying contamination sources and validating manufacturing cleanliness.

Why Particulate Analysis Testing Is Performed

Particulate matter can originate from manufacturing, packaging, or the device itself. When introduced into the body, especially intravenously, these particles may cause inflammation, allergic reactions, blood clots, or vascular occlusion. Regulatory bodies like the FDA require particulate data to evaluate the safety of devices, particularly those used in critical applications. The goal is to minimize patient exposure to harmful debris and ensure product reliability.

Have you tried our Test Navigator Tool? Try it now

Steps in Conducting Particulate Analysis Testing

1. Extraction: The device is flushed or immersed in a solution to extract particulates.
2. Filtration: The solution is filtered to collect particles.
3. Analysis: Techniques like light obscuration or microscopy are used to count and size particles.
4. Documentation: Results are recorded, and acceptance criteria are applied based on device type and clinical use.

Applicable Standards, Guidance, and Regulations

• USP <788>: Commonly used for particulate matter in injections, often adapted for device testing.
• AAMI TIR42: Offers guidance on analytical methods and setting particulate limits for vascular devices.
• FDA Guidance: The FDA may request detailed particulate data, especially for devices with direct bloodstream contact.